Home   ->   news   ->   Press Releases

Press Releases

WuXi PharmaTech Schedules First-Quarter 2011 Earnings Release

SHANGHAI, April 19, 2011 /PRNewswire via COMTEX/ --

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the first quarter of 2011 after the New York Stock Exchange closes on Tuesday, May 10, 2011 (which will be Wednesday morning, May 11, 2011 Shanghai time). The earnings release will be available on the investor relations section of its website at http://www.wuxiapptec.com.

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) on Wednesday, May 11, 2011, to discuss the first-quarter 2011 financial results and recent business activities. The conference call may be accessed by calling:


United States:

1-866-519-4004


China (Landline):

800-819-0121


China (Mobile):

400-620-8038


Hong Kong:

800-930-346


United Kingdom:

0-808-234-6646


International:

+65-6723-9381


Conference ID:

59879300






A telephone replay will be available two hours after the call's completion at:


United States:

1-866-214-5335


China North:

10-800-714-0386


China South:

10-800-140-0386


Hong Kong:

800-901-596


United Kingdom:

0-800-731-7846


International:

+61-2-8235-5000


Conference ID:

59879300






A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.

For more information, please contact:


Ronald Aldridge


Director of Investor Relations


WuXi PharmaTech (Cayman) Inc.


Tel: +1-201-585-2048


Email: Ron_Aldridge@wuxiapptec.com


Web: http://www.wuxiapptec.com



SOURCE WuXi PharmaTech (Cayman) Inc

back to top